The Prognostic Impact of MLH1 Promoter Hypermethylation in Stage I-II Endometrial Cancer Treated With Adjuvant Radiation Therapy: A Multi-Institutional Retrospective Study

Overview of attention for article published in International Journal of Radiation Oncology, Biology, Physics, May 2025

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,058 followers.

#RT #放射線治療ステージI-II子宮内膜癌の814例後ろ向き多施設研究で、MLH1プロモーター過剰メチル化群はsdMMR群より再発無増悪生存率が低く(HR1.9,p=0.025)、局所再発率も有意に高かった📊。👉https://t.co/QhEdjPUxcF

RT @Sushilberiwal: Largest dataset showing prognostic significance of MLH1- hyper methylation for endometrial cancer ⁦@KamravaMD⁩ ⁦@ASTRO_…

Largest dataset showing prognostic significance of MLH1- hyper methylation for endometrial cancer ⁦@KamravaMD⁩ ⁦@ASTRO_org⁩ ⁦@AnnKloppMD⁩ ⁦@emmacfields⁩ effort lead by Lara Hathout and her team https://t.co/u8WkjaATgA

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.